Skip to content

RxSight, Inc. RXST Return on equity

Return on equity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
LENSAR, Inc. logo
LENSAR, Inc.LNSR
-164%-235pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-68.6%+17.0pp
Precision Optics Corporation logo
Precision Optics CorporationPOCI
-29.6%-8.1pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.4%-0.9pp
Glaukos logo
GlaukosGKOS
-26.4%+11.1pp

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

Based on trailing twelve months.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s return on equity?
RxSight, Inc. (RXST) reported return on equity of -17.1% in Q1 2026.
How has RxSight, Inc.'s return on equity changed year-over-year?
RxSight, Inc.'s return on equity decreased by 42.5% year-over-year, from -12% to -17.1%.
What is the long-term trend for RxSight, Inc.'s return on equity?
Over 3 years (2022 to 2025), RxSight, Inc.'s return on equity has grown at a -37.9% compound annual growth rate (CAGR), from -58.5% to -14%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.